Marquee Background
Marquee Background

Offit Kurman Blogs

Healthcare

Advertising Compliance for Medical Devices: FTC and FDA Requirements

May 1, 2025

By Michael H. Cohen

The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) finely regulate the promotion compliance of medical devices—both in terms of the claims made and in the manner of their making. The upshot is that promotional claims about medical devices, including advertising, must be truthful and not misleading. To achieve this, the FDA and the FTC have established a series of very clear guidelines, and they have also set forth some basic, mostly “common sense” rules that any entity promoting a medical device would be wise to follow. This document is your essential guide to, and entryway into, the world of promotional compliance for medical devices.

Understanding FDA Regulations for Medical Device Labeling and Promotional Claims:

The Food and Drug Administration supervises the medical device promotional world, ensuring that claims made therein are truthful and based on solid evidence. They cover a lot of ground. The world of medical devices is not a small one, with hundreds of thousands of individual items that need to be carefully and clearly labeled. “Labeling” is a gigantic umbrella that covers any and all materials used to explain or promote the device. That means everything from brochures to website content to instructions. For a look at their comprehensive requirement list, hit up their webpage.

Scientific evidence must back medical claims. If a device manufacturer claims that the device can diagnose or treat a condition, there must be clinical data to back this up. Promoting a device for unapproved or off-label use is prohibited and can lead to enforcement actions.

For example, a developer encountered FDA fines for offering unsupported therapeutic representations about a wearable device. Once the firm fixed its labeling to drop these representations, it was able to get back on track and avoid further action. Find additional information about device labeling from the FDA at https://www.fda.gov/medical-devices/overview-device-regulation/device-labeling.

Adhering to FTC Truth-in-Advertising Standards for Medical Devices:

Ensuring the truth in advertising is the main mission of the FTC, especially when it comes to advertising for medical devices. The statements made in the promotional purview must be clear, and more importantly, they must be substantiated. This means that when a device is being promoted, the claims that are made cannot be misleading or exaggerated in any way. Furthermore, there can be no deceptive language, and absolutely no omissions that might lead the consumer to think something different than what’s actually true.

Claims related to health necessitate a great deal of proof—usually clinical trials or large-scale scientific studies. When it comes to using a person to represent a product (i.e., endorsements), the FTC requires that what is said be an accurate representation of the typical user’s experience. Also, if a person is being used to represent a product, and that person is being paid, the audience must be told so. A medical device company learned this lesson the hard way not too long ago. Visit https://www.ftc.gov/business-guidance/resources/advertising-faqs-guide-small-business for additional details.

Navigating Social Media and Digital Advertising Compliance:

When it comes to using digital platforms and social media to promote medical devices, there are defined compliance risks to consider. The FDA and FTC both have a hand in the regulation of these devices, but the FTC claims primary authority over the type of promotional speech (and the speakers) used in these venues.

Mandatory disclosures that go along with related claims should not be hard to find. They should be right there in plain view. To see what the FTC requires, rule-wise, you should look up their endorsement guides.

The same standards of truth and substantiation that apply to traditional advertising should also apply to social media posts. When influencers and affiliates promote medical devices on social media, they must ensure that their endorsements are in line with Federal Trade Commission (FTC) guidelines. This was not always the case, as evidenced by a recent revision of fitness device company social media influencer partnerships. The company in question now mandates that its partners include a clear and unmistakable disclosure of the kind of relationship they have with the company (in this case, that they are paid to promote the company’s devices). Detailed FTC disclosure requirements can be found at https://www.ftc.gov/business-guidance/resources/ftcs-endorsement-guides.

Conducting Regular Compliance Audits and Staff Training:

Regular audits of marketing materials and thorough training of marketing personnel are critical to ensure compliance with the FDA and FTC. Promotions of all kinds must meet the standards set by these two agencies. Audits should encompass all promotional content, including digital media and printed materials—to guarantee compliance.

Regular training in labeling rules, claim substantiation, and the standards of honesty in advertising should be received by the marketing teams. When audits find compliance issues, companies must take immediate and corrective actions. A medical device manufacturer has successfully implemented an advertising audit and progressed to a level of compliance in their external communication. They are a case study in being better safe than sorry when it comes to the truth in advertising. Guidance on this topic can be found on the Federal Trade Commission’s website.

Common Legal Risks and Penalties for Non-Compliance:

The FDA and FTC mandate how advertising should be done in the supplement industry, and they make it very clear which ways are not acceptable. They require actual science to back up what is said in an advertisement. They do this to ensure that consumers are not being misled. They also want to make sure that defendants in lawsuits do not have “but the supplement told me to take it” as a defense.

Compliance with FDA and FTC regulations is crucial for medical device manufacturers to avoid penalties and enhance consumer trust. Companies can achieve compliant advertising by substantiating claims, ensuring clear digital disclosures, and regularly auditing advertising practices.

Categories: Healthcare

Related People

Related Services

  • Posts
  • About
  • Subscribe

Firm Highlights

  • Events
    The 2026 Economic, Tax, and Accounting Updates
    We are looking forward to the Mid-Atlantic CFO Roundtable's next event on November 13, 2026. This is a program with topics built for Finance Executives. We are extremely fortunate to have three excellent speakers: Dr. Daraius Irani, Vice President of Business and Public Engagement at Towson University; Mike Stankus, Tax Office Managing Principal at BDO; and Daniel Wahlberg, Managing Partner of Acclare Solutions. The economy is rapidly changing with various factors driving it. The November 3rd midterm elections may also have an impact. Our three expert presenters will discuss the ramifications of the election, and the current year updates to GAAP financial reporting and Federal and State income taxes. Please join us for what will surely be an informative and timely discussion. Meet Our Speakers: Daraius Irani, Ph.D. • Towson University Vice President, Business & Public Engagement Dr. Daraius Irani serves as Vice President of Business and Public Engagement at Towson University as well as the chief economist for the Regional Economic Studies Institute (RESI) at Towson University, a policy group providing economic, fiscal impact, and policy analysis to public and private entities.  Dr. Irani is often called upon to provide economic presentations to organizations across Maryland. He has appeared on numerous television programs and in local and regional print media. Dr. Irani holds a Ph.D. in economics from University of California, Santa Barbara. Dan Wahlberg • Acclare Solutions Managing Partner With over 28 years of experience, Dan Wahlberg is a recognized leader in audit and assurance for the Mid-Atlantic’s middle market business community. As a licensed CPA in Maryland and Virginia, Dan has led assurance practices at top regional firms, including serving as Baltimore Audit Managing Partner and Assurance Practice Leader at BDO USA in Baltimore and as Partner and member of the Management Committee at Hertzbach & Company P.A which merged into BDO in 2020. His expertise centers on delivering clarity, strategic guidance, and proactive solutions to middle-market businesses across Baltimore and beyond. His entrepreneurial spirit has led him to begin a new CPA firm this year with four other CPAs serving the business community. Dan holds a Bachelor of Science in Accounting from Rutgers University and began his career at PWC in New York. He is also deeply engaged in the community, previously serving as President of ACG Maryland and current Board member and as Audit Committee Member for The Associated: Jewish Federation of Baltimore.  Mike Stankus • BDO USA LLP Tax Office Managing Principal Mike Stankus is the Tax Office Managing Principal for the firm’s Baltimore office. He has more than 16 years of experience providing tax planning and preparation and management advisory services for his clients. Mike focuses on advising privately held businesses and their owners on effective growth and tax strategies. He also performs various engagements for mergers and acquisitions and complex cost accounting projects and projections. In addition, he represents various government contracting clients before the DCAA and assists with FAR compliance. Mike’s areas of concentration include working with government contractors, professional service firms, construction companies, and homebuilders.
  • Events
    AIA Tri-State Conference
    Princeton will serve as the backdrop for three days of connection, learning, and design leadership. From keynotes to tours to the Tri-State Design Awards, this year’s conference is designed to go far beyond education sessions. Kick off the week with pre-conference intensives and individual state component Design Award celebrations, followed by three days of education, inspiration, networking, and design excellence at the 2026 AIA Tri-State Conference—featuring pre-conference intensives, three keynote speakers, 25 education sessions, curated tours, an expo, spec academies, and the AIA Tri-State Design Awards—bringing together architects and design professionals from New Jersey, New York, and Pennsylvania to connect, learn, and celebrate the best of the profession. G2. Designing Secure Practices: Cybersecurity, Data Privacy, Contractual Provisions, and Insurance Risks for Architects (4:00 PM - 5:30 PM) Architects and design professionals increasingly rely on cloud platforms, BIM software, and digital tools to manage sensitive data, creating cybersecurity and privacy risks. A single incident can trigger liability claims, regulatory obligations, reputational harm, and insurance challenges. Yet many firms underestimate how contracts, insurance, and internal practices intersect during a breach. This program offers legal and insurance perspectives on cyber risk in architecture, examining liability exposure, risky contract provisions, and mitigation strategies. A cyber insurance expert will explain policy responses, coverage gaps, coordination with professional liability, and best practices for aligning insurance with contractual risk and protecting firms from evolving cyber threats. Learning Objectives: Identify key cybersecurity and data privacy risks faced by architecture firms and explain how these risks can impact professional liability and project outcomes. Analyze common contractual provisions to determine which clauses may increase exposure to cyber incidents and propose strategies to mitigate these risks. Evaluate the scope and limitations of cyber insurance policies, including coordination with professional liability coverage, to determine how a policy would respond in a breach scenario. Develop actionable risk management strategies by integrating legal, contractual, and insurance considerations to protect sensitive client and project data.